Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEpwin Grp Regulatory News (EPWN)

  • This share is currently suspended. It was suspended at a price of 119.50
  • There is currently no data for EPWN

Transaction in Own Shares

22 Mar 2024 14:47

RNS Number : 0220I
Epwin Group PLC
22 March 2024

22 March 2024

Epwin Group Plc

("Epwin", the "Company" or the "Group")

Transaction in Own Shares

Epwin Group Plc (AIM: EPWN), announces that it has purchased ordinary shares of 0.05 pence each ("Ordinary Shares") in its issued share capital through Shore Capital in accordance with the terms of the share repurchase programme announced on 27 November 2023 (the "Programme") as follows:

(1) Date of purchase:

22 March 2024

(2) Aggregate number of Ordinary Shares purchased:

26,750

(3) Volume weighted average price per Ordinary Share (pence):

76.10

(4) Highest price per Ordinary Share (pence):

76.10

(5) Lowest price per Ordinary Share (pence):

76.10

(6) Intended treatment of purchased Ordinary Shares:

Cancellation

Following cancellation, the Group's issued share capital will comprise 142,946,942 Ordinary Shares, each with one voting right. The Company holds no ordinary shares in treasury.

The total number of voting rights in the Group will therefore be 142,946,942. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Shore Capital as part of the Programme.

Schedule of Purchases - Individual Transactions

Number of shares purchased

Transaction price (pence per share)

Time of transaction

Trading venue

26,750

76.10

14:31

AIMX

Ends.

Contact information

Epwin Group Plc

Jon Bednall, Chief Executive

Chris Empson, Group Finance Director

078 3462 3818

Shore Capital (Nominated Adviser and Joint Broker)

Corporate Advisory

Daniel Bush / Iain Sexton

Corporate Broking

Fiona Conroy

Zeus Capital Limited (Joint Broker)

Dominic King / Nick Searle

0207 408 4090

0203 829 5000

MHP

Reg Hoare / Charlie Barker / Finn Taylor

078 3462 3818

epwin@mhpc.com

About Epwin

Epwin is the leading manufacturer of energy efficient and low maintenance building products, with significant market shares, supplying the Repair, Maintenance and Improvement ("RMI"), new build and social housing sectors.

The Company is incorporated, domiciled and operates principally in the United Kingdom.

Information for investors can be accessed www.epwin.co.uk/investors/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSJTMITMTITBFI
Date   Source Headline
19th Dec 20244:25 pmRNSTransaction in Own Shares
18th Dec 20242:41 pmRNSTransaction in Own Shares
17th Dec 20242:51 pmRNSTransaction in Own Shares
16th Dec 20242:48 pmRNSTransaction in Own Shares
13th Dec 20244:23 pmRNSTransaction in Own Shares
12th Dec 20242:47 pmRNSTransaction in Own Shares
11th Dec 20243:50 pmRNSTransaction in Own Shares
10th Dec 20243:39 pmRNSTransaction in Own Shares
9th Dec 20242:43 pmRNSTransaction in Own Shares
6th Dec 20242:56 pmRNSTransaction in Own Shares
5th Dec 202412:30 pmRNSTransaction in Own Shares
4th Dec 20243:45 pmRNSTransaction in Own Shares
3rd Dec 202411:22 amRNSTransaction in Own Shares
2nd Dec 20241:00 pmRNSTransaction in Own Shares
29th Nov 20244:10 pmRNSTransaction in Own Shares
28th Nov 20244:37 pmRNSTransaction in Own Shares
27th Nov 20243:37 pmRNSTransaction in Own Shares
26th Nov 20243:31 pmRNSTransaction in Own Shares
25th Nov 20243:30 pmRNSTransaction in Own Shares
22nd Nov 20244:56 pmRNSTransaction in Own Shares
22nd Nov 20241:22 pmRNSHolding(s) in Company
20th Nov 20242:49 pmRNSTransaction in Own Shares
19th Nov 20244:01 pmRNSTransaction in Own Shares
18th Nov 20243:21 pmRNSTransaction in Own Shares
15th Nov 20244:44 pmRNSTransaction in Own Shares
15th Nov 20247:00 amRNSGrant of Options under SAYE Scheme
14th Nov 20243:51 pmRNSTransaction in Own Shares
13th Nov 202412:52 pmRNSTransaction in Own Shares
12th Nov 20245:15 pmRNSTransaction in Own Shares
11th Nov 20243:08 pmRNSTransaction in Own Shares
8th Nov 20244:57 pmRNSTransaction in Own Shares
7th Nov 20246:02 pmRNSTransaction in Own Shares
6th Nov 20244:59 pmRNSTransaction in Own Shares
4th Nov 20244:52 pmRNSTransaction in Own Shares
31st Oct 20245:05 pmRNSTransaction in Own Shares
30th Oct 20245:08 pmRNSTransaction in Own Shares
29th Oct 20245:11 pmRNSTransaction in Own Shares
25th Oct 20244:40 pmRNSTransaction in Own Shares
24th Oct 20244:10 pmRNSTransaction in Own Shares
23rd Oct 20242:56 pmRNSTransaction in Own Shares
22nd Oct 20245:03 pmRNSTransaction in Own Shares
21st Oct 202411:14 amRNSTransaction in Own Shares
18th Oct 20245:06 pmRNSTransaction in Own Shares
15th Oct 20244:56 pmRNSTransaction in Own Shares
14th Oct 20244:50 pmRNSTransaction in Own Shares
11th Oct 20244:07 pmRNSTransaction in Own Shares
9th Oct 20244:44 pmRNSTransaction in Own Shares
7th Oct 20245:04 pmRNSTransaction in Own Shares
4th Oct 20243:06 pmRNSTransaction in Own Shares
3rd Oct 20241:56 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.